AMGEN INC Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amgen Inc quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Amgen Inc Operating Income (Loss) for the quarter ending September 30, 2024 was $2.05B, a 1.29% increase year-over-year.
  • Amgen Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was $6.22B, a 29.8% decline year-over-year.
  • Amgen Inc annual Operating Income (Loss) for 2023 was $7.9B, a 17.4% decline from 2022.
  • Amgen Inc annual Operating Income (Loss) for 2022 was $9.57B, a 25.2% increase from 2021.
  • Amgen Inc annual Operating Income (Loss) for 2021 was $7.64B, a 16.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $7.9B -$1.67B -17.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-14
2022 $9.57B +$1.93B +25.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-14
2021 $7.64B -$1.5B -16.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-14
2020 $9.14B -$535M -5.53% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $9.67B -$589M -5.74% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-16
2018 $10.3B +$290M +2.91% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-09
2017 $9.97B +$179M +1.83% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-12
2016 $9.79B +$1.32B +15.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-13
2015 $8.47B +$2.28B +36.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-13
2014 $6.19B +$324M +5.52% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-14
2013 $5.87B +$290M +5.2% Jan 1, 2013 Dec 31, 2013 8-K 2016-10-31
2012 $5.58B +$1.27B +29.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-19
2011 $4.31B -$1.23B -22.2% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-24
2010 $5.55B Jan 1, 2010 Dec 31, 2010 10-K 2013-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.